Clinical Study on Natural Treatment against HPV and Herpes is the Most Downloaded Paper from Medical Journal

Share Article

The CBCD is delighted to announce that its published paper on the natural, antiviral formula of Novirin and Gene-Eden-VIR is now the most downloaded and read study in the medical journal Pharmacology & Pharmacy.

News Image
The success of this paper indicates the great interest the medical community has in natural products. This success strengthens our resolve to conduct research on the safety and effectiveness of natural treatments. - Greg Bennett, CBCD

The paper entitled “Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study” was published in the medical journal Pharmacology & Pharmacy in August 2013. Since then, in just 16 months, it has been viewed over 18,000 times, and has been downloaded over 4,404 times by members of the medical community. That translates to more than 1,000 reads, and almost 300 downloads per month! This means that on a monthly basis, it is the most downloaded and read paper in the history of the medical journal. Overall, it is currently the third most read, and is projected to soon become the most read, scientific paper in the history of Pharmacology & Pharmacy. Moreover, due to the breakthrough results of the study, many doctors are currently prescribing the natural antiviral supplement, Gene-Eden-VIR to help the immune system target the latent form of viruses in the herpes family of viruses, the human papillomavirus (HPV), EBV, CMV, and HCV.

The CBCD encourages members of the medical community, including doctors, biologists, virologists, and other scientists, to read the study if they have not already done so. The study can be viewed and downloaded by clicking on the following link:

http://tinyurl.com/nrfq5u8

The formula of Novirin and Gene-Eden-VIR was tested by Hanan Polansky and Edan Itzkovitz from the CBCD. The studies showed that the Gene-Eden-VIR and Novirin formula is effective against the family of herpes viruses, including HSV-1 and HSV-2. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with (HSV-1 or HSV-2)…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (1) The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (1)

Both products can be ordered online on the Novirin and Gene-Eden-VIR websites.

Gene-Eden-VIR and Novirin are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinensis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Gene-Eden-VIR and Novirin are the only natural antiviral products on the market with published clinical studies that support their claims.

“The success of this paper indicates the great interest the medical community has in natural products. This success strengthens our resolve to conduct research on the safety and effectiveness of natural treatments against the chronic diseases impacting millions of people. We hope that in the future, the CBCD will be recognized as the leader in clinical research on natural treatments.” – Greg Bennett, CBCD

Click to learn more about Novirin. Click to learn more about Gene-Eden-VIR.

Reference:

(1) Polansky, H. Itzkovitz, E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Greg Bennett
CBCD
+1 5852509999
Email >
Visit website